Mid-Atlantic Cancer Genetics Network, breast cancer, ovarian cancer study

2of 3

Breast/Ovarian Cancer __________________________________________________________________

Study Name

Genetic Modifiers of BRCA1 and BRCA2 in Mutation Carriers (GEMS)

Description

This multi-center Breast Cancer Study will recruit approximately 1000 women who have had breast cancer and were tested for an inherited alteration in the BRCA1 and/or BRCA2 genes. Individuals are eligible if their test results were either positive or negative. Alterations in these genes increase the chance of developing breast and ovarian cancer. This type of research may lead to improved diagnosis, improved treatment, and possibly, prevention of inherited cancers.

Eligible candidates must:

Be 18 years of age or older
Have a diagnosis of invasive or in situ (DCIS) breast cancer
Be tested for a BRCA1 and/or BRCA2 mutation either prior to the breast cancer diagnosis or no more than 3 years after the breast cancer diagnosis

Participants will:

complete a 30-40 minute questionnaire about medical history and health habits
sign a medical records release form for review of medical information and gene testing
provide a blood sample
review and sign a study consent form

Principal Investigator

Kala Visvanathan, M.D.

Contact Information

Cheryl Pendergrass, MS

Study Coordinator/Genetic Counselor

(410) 614-2667 or 1-877-880-6188

Jennifer Axilbund, MS, CGC

Study Coordinator/Genetic Counselor

(410) 614-0378 or 1-877-880-6188

� 2001-2 Mid-Atlantic Cancer Genetics Network modified 10/20/05 Privacy Statement Questions/Comments [email protected]